(Press-News.org) Posters
All poster presentations will take place on Monday, June 12, 2023, from 12:15 to 1:30 p.m. EDT, or Tuesday, June 13, 2023, from 12:15 to 1:30 p.m. EDT at the Baltimore Convention Center, Exhibit Hall E, Level 100.
Abstract 4-M (Monday)
Avoiding Clinical Inertia: Comparing Time to Intensification of Glucagon-like
peptide-1 (GLP-1) Receptor Agonists in Patients with Type 2 Diabetes Mellitus Among Clinical Pharmacists versus Providers
Clinical pharmacists have a significant impact on medication optimization and reduction of HbA1c when included in collaborative patient care in the outpatient setting. A retrospective chart review was conducted to examine the impact of a clinical pharmacist on the treatment intensification of GLP-1 receptor agonists in patients with type 2 diabetes versus the typical standard of care without pharmacist involvement. Researchers reviewed the charts of 28 patients with type 2 diabetes who were prescribed semaglutide, liraglutide or dulaglutide and who had an HbA1c over 7%. The study found 85% of patients who received care from clinical pharmacists had their GLP-1 agonist titrated to the first effective dose in the recommended timeframe, compared to just 12.5% of patients who received standard of care. Patients treated by pharmacists also had a significantly larger reduction in HbA1c and faster time to treatment intensification beyond the first effect dose.
Abstract 25-T (Tuesday)
Price Transparency at the Point of Prescribing with Real-Time Prescription Benefits
Real-time prescription benefits (RTPB) is a tool that provides prescribers with patient-, medication-, and pharmacy-specific information on how much a medication is estimated to cost, if a prior authorization is needed, and if there are any lower-cost alternatives. The program displays an alert to physicians prescribing medication that alerts the prescriber to prior authorization requirements, price estimates, and alternative medication options. Researchers analyzed prescribing and RTPB data from March 2022 to March 2023 at Vanderbilt University Medical Center to determine the proportion of patients who picked up their medications, whether the system triggered an alert and whether an alternative was accepted. The results showed that about 5% of prescriptions generated alerts, with 77% alerting to a lower-cost alternative. When prescribers were alerted to and chose a lower cost alternative to prescriptions they were writing, patients were 15% more likely to pick up the prescription.
Abstract 38-T (Tuesday)
Assessment of Second Victim Experience Among Pharmacy Staff at a Comprehensive Cancer Center (Note the author and an ASHP expert will hold a media availability on this topic, at 2 p.m. EDT, Tuesday, June 13, in Room 346, Baltimore Convention Center. For more information, to obtain a media registration, or to arrange interviews or remote participation, contact Aretha Hankinson, ahankinson@ASHP.org.)
Second victims are healthcare providers who are involved in unexpected adverse patient events, errors, and/or patient-related injuries and experience personal trauma related to the event. This single-center, retrospective, descriptive study aimed to evaluate current pharmacy staff support for second victims at a major comprehensive cancer center. A 10-item survey aimed at evaluating current staff support for second victims was administered to pharmacy staff between February and March 2023, with 137 pharmacy staff, administrators and trainees responding. More than 1 in 5 respondents reported being involved in an unanticipated clinical event that left them feeling anxious, depressed and uncertain about their ability to do their jobs, yet nearly three-quarters had never heard the term “second victim.” Over half the respondents involved in an adverse patient event received no support from anyone after the event. Results suggest a lack of awareness regarding the second-victim phenomenon.
About the ASHP Summer Meetings & Exposition
ASHP’s Summer Meetings and Exhibition provides focused education and networking in pharmacy specializations. The meetings also wrap up ASHP’s policy year with the proceedings of the House of Delegates and features the inauguration of new officers and board members, hosts. The meeting program includes poster presentations and exhibits featuring the latest products, services and technologies in the industry.
About ASHP
ASHP is the largest association of pharmacy professionals in the United States, representing 60,000 pharmacists, student pharmacists, and pharmacy technicians in all patient care settings, including hospitals, ambulatory clinics, and health-system community pharmacies. For over 80 years, ASHP has championed innovation in pharmacy practice, advanced education and professional development, and served as a steadfast advocate for members and patients. In addition, ASHP is the accrediting body for pharmacy residency and technician training programs and provides comprehensive resources to support pharmacy professionals through every stage of their careers. For more information, visit ashp.org and ASHP’s consumer website, SafeMedication.com.
END
ASHP Summer Meeting Tip Sheet
2023-06-13
ELSE PRESS RELEASES FROM THIS DATE:
MOVA: new method for evaluating the pathogenicity of missense variants using AlphaFold2
2023-06-13
Niigata, Japan - The Department of Neurology at Niigata University has developed a new in silico method for evaluating the pathogenicity of missense variants using AlphaFold2 (MOVA). Rare variants in the causative gene of ALS are present in 10-30% of sporadic ALS cases, which highlights the need for accurate and efficient pathogenicity prediction methods. To predict the pathogenicity of the variants, in silico analysis methods are commonly used. In some ALS causal genes, the mutations are concentrated in specific regions, and the accuracy of pathogenicity prediction can be improved by considering the positional information of the variants. ...
23Na MRI technique unleashes new approach for diagnosing diabetic kidney disease
2023-06-13
Niigata, Japan - The gold standard test for predicting the onset of diabetic kidney disease is albuminuria. However, detecting albuminuria alone has limited sensitivity and specificity in end-stage renal failure with a decreased estimated glomerular filtration rate. This is supported by several reports, which state that about half of the type 2 diabetes patients who developed kidney dysfunction showed no preceding albuminuria.
In this study, the authors propose the possibility of diagnosing tubular abnormalities in diabetic kidney disease at an early stage and connecting them to treatment by combining the evaluation of sodium concentration using 23Na MRI ...
Immune cell movement worse in older females, mice study finds
2023-06-13
Older female mice had more immune cells entering areas of the body where they shouldn’t according to a new study, demonstrating that sex differences contribute to age-related inflammation that needs to be considered in future research.
In a paper published in Journal of Leukocyte Biology today (Tuesday 13 June), at team of researchers led by Dr Myriam Chimen from the University of Birmingham have found that age significantly increases the number of immune cells entering the sack that holds major organs (peritoneal cavity) in female mice, when compared to young mice or older male mice.
The findings support previous studies that suggest ...
THE LANCET: First phase 3 trial of a chikungunya vaccine candidate finds it is generally safe and provokes an immune response
2023-06-13
Peer-reviewed / Randomised Controlled Trial / People
Study of healthy US adults found that a single dose of the VLA1553 vaccine candidate was generally safe, well tolerated and provokes an immune response.
After a single vaccination, the vaccine produced neutralizing antibody levels which are thought to protect against chikungunya disease in 99% (263/266) of participants.
Antibody levels declined 28 days after vaccination, but seroprotection persisted in more than 96% (233/242) participants after six months.
Most adverse events were moderate or mild and the authors say its safety profile is similar to other licensed vaccines
The VLA1553 vaccine candidate ...
The chatbot will see you now:
2023-06-13
Glasgow, UK: The informed consent process in biomedical research is biased towards people who can meet with clinical study staff during the working day. For those who have the availability to have a consent conversation, the time burden can be off-putting. Professor Eric Vilain, from the Department of Paediatrics, University of California, Irvine, USA, will tell the European Society of Human Genetics annual conference today (Tuesday 13 June) how results from his team’s study of the use of a chatbot (GIA – ‘Genetics Information Assistant’ ...
NHS policies on patient’s weight and access to hip replacement surgery are inappropriate, study finds
2023-06-13
Weight and body mass index (BMI) policies introduced by NHS commissioning groups in England are inappropriate and worsening health inequalities, according to a new study published in BMC Medicine today [13 June] that analysed nearly 490,000 hip surgeries. With one in ten people likely to need a joint replacement in their lifetime, many thousands of patients are directly affected by these policies.
Rules implemented by NHS clinical commissioning groups (CCGs) across England to change the access to hip and knee replacement surgery for patients who are overweight or obese have been in effect for over ten years. ...
A baking soda solution for clean hydrogen storage
2023-06-13
In a world of continuously warmer temperatures, a growing consensus demands that energy sources have zero, or next-to-zero, carbon emissions. That means growing beyond coal, oil, and natural gas by getting more energy from renewable sources.
One of the most promising renewable energy carriers is clean hydrogen, which is produced without fossil fuels.
It’s a promising idea because the most abundant element in the universe is hydrogen, found in 75 percent of all matter. Moreover, a hydrogen molecule has two paired atoms—Gemini twins that are both non-toxic and highly combustible.
Hydrogen’s combustive potential ...
Can this medication reverse MS? Brain biomarker shows it can
2023-06-13
A decade after UC San Francisco scientists identified an over-the-counter antihistamine as a treatment for multiple sclerosis, researchers have developed an approach to measure the drug’s effectiveness in repairing the brain, making it possible to also assess future therapies for the devastating disorder.
The researchers, led by physician-scientist Ari Green, MD, who together with neuroscientist Jonah Chan, PhD, first identified clemastine as a potential MS therapy, used MRI scans to study the drug’s impact on the brain of 50 participants in a clinical study.
In MS, patients lose myelin, the protective insulation around ...
The advances and promise of continuous glucose monitoring in diabetes management
2023-06-13
As adoption of Continuous Glucose Monitoring (CGM) continues to increase, there is a growing body of evidence supporting the use of this technology in improving diabetes outcomes for patients with Type 1 or Type 2 Diabetes. A new supplement in the peer-reviewed journal Diabetes Technology & Therapeutics (DTT) provides an excellent perspective of the past, present, and future of CGM. Click here to read the supplement now.
In the supplement Rickson et al. review the rapid pace in which diabetes technology has progressed and the implications for relying on rigorous and extensive timelines to publish randomized controlled trials to impact ...
Ochsner Health names new chief financial officer and treasurer
2023-06-13
NEW ORLEANS, La. – Ochsner Health has named Jim Molloy as the organization’s next Executive Vice President, Chief Financial Officer and Treasurer. A leader at Citi bringing decades of extensive experience in healthcare finance, Molloy will oversee the organization’s accounting, financial planning and analysis, reimbursement and revenue cycle functions, as well as managed care contracting and treasury. He will also play a pivotal role in the continued development and execution of ...